MyMD Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MYMD and buy or sell other stocks, ETFs, and their options commission-free!About MYMD
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms.
CEOChristopher C. Chapman, Jr., MD
CEOChristopher C. Chapman, Jr., MD
Employees2
Employees2
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1989
Founded1989
Employees2
Employees2
MYMD Key Statistics
Market cap143.82K
Market cap143.82K
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume20.22M
Average volume20.22M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$158.00
52 Week high$158.00
52 Week low$2.50
52 Week low$2.50
Stock Snapshot
With a market cap of 143.82K, MyMD Pharmaceuticals(MYMD) trades at $0.05. The stock has a price-to-earnings ratio of -0.03.
During the trading day, MyMD Pharmaceuticals(MYMD) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for MyMD Pharmaceuticals(MYMD) stock has reached 0, versus its average volume of 20.22M.
Over the past 52 weeks, MyMD Pharmaceuticals(MYMD) stock has traded between a high of $158.00 and a low of $2.50.
Over the past 52 weeks, MyMD Pharmaceuticals(MYMD) stock has traded between a high of $158.00 and a low of $2.50.
People also own
Based on the portfolios of people who own MYMD. This list is generated using Robinhood data, and it’s not a recommendation.